Company / Working Capital per Share
BioRestorative Therapies, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$0.08
FY2025
5-year range
-$0.08 / $29.49
FY2021-FY2025
Trend
-105.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 4 consecutive years, from $29.49 in FY2021 to $-0.08 in FY2025.
Based on SEC 10-K filings.
-0.08 in FY2025.
Declined from $2.39 to $-0.08 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- BioRestorative Therapies, Inc.'s working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 105.4% year-over-year.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.08 | -105.4% |
| FY2024 | $1.57 | -34.2% |
| FY2023 | $2.39 | -42.8% |
| FY2022 | $4.17 | -85.9% |
| FY2021 | $29.49 | +107084.5% |
| FY2020 | $0.03 | +102.4% |
| FY2019 | -$1.16 | +21.6% |
| FY2018 | -$1.48 | +11.0% |
| FY2017 | -$1.67 | +4.6% |
| FY2016 | -$1.75 | +44.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026